Literature DB >> 9374341

Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.

S Kim1, H N Wagner, V L Villemagne, P F Kao, R F Dannals, H T Ravert, T Joh, R B Dixon, A C Civelek.   

Abstract

UNLABELLED: Surgical procedures usually involve the administration of narcotic drugs as anesthetics or adjuvants. To reverse the effects of anesthesia, opioid antagonists such as naloxone are commonly used. Due to its short lasting effects, patients receiving naloxone must be monitored carefully. Nalmefene, a pure opiate antagonist with a longer duration of action than naloxone, has shown promise in the reversal of opioid anesthesia.
METHODS: A simple dual-detector positron radiation detector system and [11C]carfentanil were used to compare the duration of blockade of cerebral mu opioid receptors by naloxone and nalmefene in eight normal volunteers. Carbon-11-carfentanil brain kinetics were monitored for 5 min and 2, 4, 8 and 24 hr after the administration of either nalmefene (1 mg or 1 microg/kg) or naloxone (2 mg or 2 microg/kg). Blood samples were obtained at the same times for plasma determinations.
RESULTS: Clearance half-times from opioid receptors were 28.7 +/- 5.9 hr for 1 mg of nalmefene and 2.0 +/- 1.6 hr for 2 mg of naloxone. Brain clearance times were about 21.1 and 3.4 times slower than plasma clearance times for nalmefene and naloxone, respectively.
CONCLUSION: These findings suggest that the prolonged effects of nalmefene are related to the slow dissociation of nalmefene from opioid receptors, which are not reflected in the plasma curve. This longer blockade of opioid receptors by nalmefene represents an advantage in the clinical management of postsurgical reversal of narcotic anesthesia and opioid side effects as well as the reversal of opioid overdose.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374341

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

Review 1.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

2.  Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ-opioid receptor occupancy.

Authors:  Lars-Erik Broksoe Kyhl; Shen Li; Kirstine Ullitz Faerch; Birgitte Soegaard; Frank Larsen; Johan Areberg
Journal:  Br J Clin Pharmacol       Date:  2016-01-27       Impact factor: 4.335

Review 3.  [Nalmefene: a novel pharmacotherapeutic option for alcoholism].

Authors:  M Soyka
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

4.  Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.

Authors:  Philip Krieter; C Nora Chiang; Shwe Gyaw; Phil Skolnick; Rebekah Snyder
Journal:  Drug Metab Dispos       Date:  2019-04-16       Impact factor: 3.922

5.  Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Authors:  Jarkko Johansson; Jussi Hirvonen; Zsófia Lovró; Laura Ekblad; Valtteri Kaasinen; Olli Rajasilta; Semi Helin; Jouni Tuisku; Saija Sirén; Mirka Pennanen; Arvind Agrawal; Roger Crystal; Petri J Vainio; Hannu Alho; Mika Scheinin
Journal:  Neuropsychopharmacology       Date:  2019-03-13       Impact factor: 7.853

6.  Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade.

Authors:  Martin Trøstheim; Marie Eikemo; Jan Haaker; J James Frost; Siri Leknes
Journal:  Neuropsychopharmacology       Date:  2022-08-17       Impact factor: 8.294

7.  Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin.

Authors:  James Courtney; Edward Boyer
Journal:  J Med Toxicol       Date:  2008-09

8.  A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative pain.

Authors:  Smita Kshirsagar; Robert Gear; Jon Levine; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

9.  Multiple Fentanyl Overdoses - New Haven, Connecticut, June 23, 2016.

Authors:  Anthony J Tomassoni; Kathryn F Hawk; Karen Jubanyik; Daniel P Nogee; Thomas Durant; Kara L Lynch; Rushaben Patel; David Dinh; Andrew Ulrich; Gail D'Onofrio
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-03       Impact factor: 17.586

Review 10.  Imaging of opioid receptors in the central nervous system.

Authors:  Gjermund Henriksen; Frode Willoch
Journal:  Brain       Date:  2007-11-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.